Extracellular Vesicle (EV) Targeted Cells Release Secondary Effector EVs: Indication of How To Account for Histocompatibility and Disease Specificity of EV Treatments

Documenti analoghi

• Lipidome Analysis of Cancer Cells and Their Extracellular Vesicles Reveals Cancer‐Type‐Specific Lipid Signatures and Enables the Design of EV‐Mimetic Liposomes
  di: Noélie Douanne, et al.
  Pubblicazione: (2026)
• Is Secondary Vesicle Release an Underappreciated Component of Extracellular Vesicle Signalling?
  di: Gary Sweeney, et al.
  Pubblicazione: (2025)
• Correction to "DetectEV: a Functional Enzymatic Assay to Assess Integrity and Bioactivity of Extracellular Vesicles"
  Pubblicazione: (2025)
• VesicleVoyager: In Vivo Selection of Surface Displayed Proteins That Direct Extracellular Vesicles to Tissue‐Specific Targets
  di: Yuki Kawai‐Harada, et al.
  Pubblicazione: (2025)
• Single‐extracellular vesicle (EV) analyses validate the use of L1 Cell Adhesion Molecule (L1CAM) as a reliable biomarker of neuron‐derived EVs
  di: Carlos J Nogueras‐Ortiz, et al.
  Pubblicazione: (2024)